|

|
Glutathione Articles - ALS (Amyotrophic
Lateral Sclerosis)
-
Cudkowicz ME, Sexton PM, Ellis T, Hayden DL, Gwilt PR, Whalen J and Brown
RH, Jr. The pharmacokinetics and
pharmacodynamics of procysteine in amyotrophic lateral sclerosis.
Neurology. 1999 Apr 22;52(7):1492-4.
-
Kuzma M, Jamrozik Z,
Baranczyk-Kuzma A. Activity and
expression of glutathione S-transferase pi in patients with amyotrophic
lateral sclerosis. Clin Chim Acta. 2006 Feb;364(1-2):217-21.
Epub 2005 Aug 18.
-
Tohgi H, Abe T, Yamazaki K,
Murata T, Ishizaki E, Isobe C.
Increase in oxidized NO products and reduction in oxidized glutathione in
cerebrospinal fluid from patients with sporadic form of amyotrophic
lateral sclerosis. Neurosci Lett. 1999 Feb 5;260(3):204-6.
-
Usarek E, Gajewska B,
Kazmierczak B, Kuzma M, Dziewulska D, Baranczyk-Kuzma A.
A Study of Glutathione S-transferase pi
Expression in Central Nervous System of Subjects with Amyotrophic
Lateral Sclerosis Using RNA Extraction from Formalin-Fixed,
Paraffin-Embedded Material. Neurochemical Research, Vol. 30,
No. 8, August 2005:1003–1007.
-
Tartari S, D'Alessandro G,
Babetto E, Rizzardini M, Conforti L, Cantoni L.
Adaptation to G93Asuperoxide dismutase
1 in a motor neuron cell line model of amyotrophic lateral sclerosis:
The role of glutathione. FEBS J. 2009 May;276(10):2861-74.
-
Chi L, Ke Y, Luo C, Gozal D,
Liu R.
Depletion of Reduced Glutathione
Enhances Motor Neuron
Degeneration in vitro and in vivo.
Neuroscience. 2007
February 9; 144(3): 991–1003.
If you would like us to send
you abstracts of any of the articles listed above (or full text PDF's when
available), please contact us by phone or e-mail:
Caron
Lassiter
|
 |